跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES
Approved
STANDARD
OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES
Takeda France S.A.S.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 17, 2024
Approval ID
609b906df65b8abb
Company
Takeda France S.A.S.
Type
Standard
Approval Details
Approval Id
609b906df65b8abb
Drug Cima Aemps Name
OPIREN FLAS 30 mg COMPRIMIDOS BUCODISPERSABLES
Register Number
3400936871441
Holder Company Name
Takeda France S.A.S.
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2024-05-17
Dosage Form
COMPRIMIDO BUCODISPERSABLE
Dose
30 mg lansoprazol
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Takeda France S.A.S.
Active Ingredients
LANSOPRAZOL
30,0 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 17, 2024
Approval ID
609b906df65b8abb
Type
Standard
Back to CIMA-AEMPS Approvals
